Huntington's disease (HD) is a fatal hereditary neurodegenerative disorder caused by an expanded cytosine-adenine-guanine (CAG) repeat sequence in the first exon of the huntingtin (HTT) gene. The disease is characterised by motor impairment, cognitive deterioration, behavioural problems and progressive weight loss. Although less well-known, autonomic nervous system dysfunction can also accompany HD. In this article, we delineate the characteristics and correlates of autonomic symptoms in HD. In addition, we provide an overview of autonomic defects that have been found thus far by means of standardised autonomic function tests in HD, discuss their pathophysiological meaning and point to perspectives for future research in this area. In conclusion it can be stated that autonomic symptoms are highly prevalent in HD patients and may even precede the onset of motor signs. Moreover, autonomic dysfunction appears to be related to functional disability and depression in HD. Therefore, increased clinical awareness and adequate management of autonomic symptoms may lead to a considerable improvement in quality of life.
Neurodegenerative Disease Huntington's Disease DOI:10.17925/ENR.2010.05.02.46 symptoms in HD patients were early abdominal fullness, straining for defecation, faecal and urinary incontinence, urgency, incomplete bladder emptying and light-headedness while standing up. Of these symptoms, only swallowing difficulties, sialorrhoea, urgency, and erection and ejaculation problems were also more frequent in HD patients compared with premanifest mutation carriers.
Premanifest mutation carriers experienced significantly more swallowing difficulties and light-headedness on standing up compared with controls. Motor impairment, as defined by the motor subscore of the Unified Huntington's Disease Rating Scale (UHDRS), was not significantly associated with the degree of autonomic dysfunction in HD patients, even when various autonomic domains were analysed separately. In fact, only functional indices, i.e. total functional capacity, functional assessment and independence score, appeared to be significantly associated with autonomic dysfunction in HD patients.
Moreover, the severity of autonomic symptoms also positively correlated with depressive symptoms and use of antidepressant drugs. Interestingly, depressive symptoms were identified as the only independent predictor of the degree of autonomic dysfunction in HD patients, accounting for 32% of the variation.
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The most prominent autonomic complaints in HD patients concerned the gastrointestinal tract, including swallowing difficulties, dysphagia and sialorrhoea.
These symptoms may partly be accounted for by skeletal muscle inco-ordination due to striatal pathology.
11 However, the absence of an association between gastrointestinal symptoms and UHDRS motor score, as well as the relatively high prevalence of swallowing difficulties even in premanifest mutation carriers, suggests that ANS dysfunction is also The association between autonomic symptoms and both functional disability and depression in HD patients is intriguing. Although it is difficult to differentiate between cause and effect, autonomic symptoms are unlikely to be secondary to functional impairment, as, by definition, autonomic functions are not under voluntary control. It is rather more likely that symptoms such as dysphagia, sialorrhoea, and faecal and urinary incontinence could lead to social embarrassment, isolation and a negative impact on daily functioning.
On the other hand, the relation between autonomic dysfunction and depression, which is also found in, e.g., Parkinson's disease, 23 is harder to explain since depression itself can be accompanied by several vegetative symptoms such as loss of libido. 24 In fact, depression has been shown to be the only independent predictor of autonomic dysfunction in HD patients, indicating that its effect on autonomic symptoms is independent of, e.g. functional disability.
Although antidepressant use was correlated with the extent of autonomic complaints in HD patients, adjustment for the severity of depressive symptoms rendered this relation insignificant, 20 suggesting that the association between depression and autonomic dysfunction is unlikely to be secondary to medication. Longitudinal studies of autonomic symptoms are needed to more precisely delineate the temporal association between depression and autonomic dysfunction in HD. Decreased heart rate variability in HD patients, as reflected by a high LFB/HFB ratio, may thus actually result from increased sympathetic activity, decreased vagal modulation or a combination of both.
Autonomic Function Tests in Huntington's Disease
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Therefore, further investigations are needed to elucidate which pathway is predominantly involved. Interestingly, the prolonged SSR Autonomic Symptoms in Huntington's Disease Aziz et al., 2010. 20 latencies, smaller amplitudes and lower HRV detected in HD patients by some investigators seemed to closely correlate with various components of the UHDRS scores, 26, 27 suggesting that these measures may be useful as biomarkers to track disease progression.
Pathophysiology of Autonomic Dysfunction in Huntington's Disease
The exact origin of impaired ANS function in individuals with HD remains to be elucidated. However, based on current knowledge, several possible explanations may account for autonomic dysfunction in HD. As there are no reasons to suspect damage to the peripheral nervous system in HD, 18,26,27 the site of autonomic dysfunction is likely to be found in the central autonomic network including the hypothalamus and its connections to the cortex, limbic system, brainstem and spinal cord. 29 Substantial hypothalamic pathology has indeed been found in both HD patients and animal models of the disease.
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Recently, a significant loss of dopamine D2 receptors, as well as microglial activation, was found in the hypothalamus of both HD patients and premanifest mutation carriers. 31 As these abnormalities, as well as neuronal inclusions of mutant huntingtin, were seen throughout the hypothalamus, 31,32 hypothalamic damage might account for the autonomic dysfunction that encompasses both sympathetic and parasympathetic functions. 18, [25] [26] [27] Alternatively, ANS dysfunction in HD, particularly sympathetic hyperactivity, might be interpreted as a release phenomenon due to diminished output from higher-order cortical regions to brainstem autonomic centers. 
Management of Autonomic Complaints in Huntington's Disease
Unfortunately, there are no clinical studies available that specifically address the management of autonomic complaints in HD patients. 
